These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 20878481)
1. Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism. Ismail D; Hussain K Rev Endocr Metab Disord; 2010 Sep; 11(3):165-9. PubMed ID: 20878481 [TBL] [Abstract][Full Text] [Related]
2. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective. Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890 [TBL] [Abstract][Full Text] [Related]
4. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy. Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668 [TBL] [Abstract][Full Text] [Related]
5. The role of Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747 [TBL] [Abstract][Full Text] [Related]
6. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism. Yang J; Yuan L; Meeks JK; Zhang N; Li C; Hao R J Pediatr Endocrinol Metab; 2012; 25(7-8):619-22. PubMed ID: 23155683 [TBL] [Abstract][Full Text] [Related]
7. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476 [TBL] [Abstract][Full Text] [Related]
8. Congenital hyperinsulinism treated by surgical resection of the hyperplastic lesion which had been preoperatively diagnosed by 18F-DOPA PET examination in Japan: a nationwide survey. Kanamori Y; Watanabe T; Yorifuji T; Masue M; Sasaki H; Nio M Pediatr Surg Int; 2018 Oct; 34(10):1093-1098. PubMed ID: 30076450 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294 [TBL] [Abstract][Full Text] [Related]
10. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030 [TBL] [Abstract][Full Text] [Related]
12. States LJ; Davis JC; Hamel SM; Becker SA; Zhuang H J Nucl Med; 2021 Jul; 62(Suppl 2):51S-56S. PubMed ID: 34230074 [TBL] [Abstract][Full Text] [Related]
13. 18-F-L 3,4-Dihydroxyphenylalanine PET/Computed Tomography in the Management of Congenital Hyperinsulinism. States LJ; Saade-Lemus S; De Leon DD PET Clin; 2020 Jul; 15(3):349-359. PubMed ID: 32498990 [TBL] [Abstract][Full Text] [Related]
14. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation. Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340 [TBL] [Abstract][Full Text] [Related]
15. The heterogeneity of focal forms of congenital hyperinsulinism. Ismail D; Kapoor RR; Smith VV; Ashworth M; Blankenstein O; Pierro A; Flanagan SE; Ellard S; Hussain K J Clin Endocrinol Metab; 2012 Jan; 97(1):E94-9. PubMed ID: 22031516 [TBL] [Abstract][Full Text] [Related]
16. Congenital hyperinsulinism: localization of a focal lesion with States LJ; Becker SA; De León DD Pediatr Radiol; 2022 Apr; 52(4):693-701. PubMed ID: 34668049 [TBL] [Abstract][Full Text] [Related]
17. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan. Masue M; Nishibori H; Fukuyama S; Yoshizawa A; Okamoto S; Doi R; Uemoto S; Tokumi T; Kasai T; Yorifuji T Clin Endocrinol (Oxf); 2011 Sep; 75(3):342-6. PubMed ID: 21521340 [TBL] [Abstract][Full Text] [Related]
19. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism. Capito C; Khen-Dunlop N; Ribeiro MJ; Brunelle F; Aigrain Y; Crétolle C; Jaubert F; De Lonlay P; Nihoul-Fékété C Radiology; 2009 Oct; 253(1):216-22. PubMed ID: 19709999 [TBL] [Abstract][Full Text] [Related]